We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News

The Tan Sheet

Executive Summary

OTC drug therapy during the early stages of upper respiratory infections (URIs) could save up to $4.75 bil. annually in the U.S., according to an analysis conducted by Martin Lipsky, MD, Northwestern University, Feinberg School of Medicine, et al